These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 26477622)
21. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease. Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982 [TBL] [Abstract][Full Text] [Related]
22. Targeting cysteine proteases in trypanosomatid disease drug discovery. Ferreira LG; Andricopulo AD Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388 [TBL] [Abstract][Full Text] [Related]
23. Current status of Chagas disease chemotherapy. Guedes PM; Silva GK; Gutierrez FR; Silva JS Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270 [TBL] [Abstract][Full Text] [Related]
24. Chagas disease: progress and new perspectives. Sánchez-Sancho F; Campillo NE; Páez JA Curr Med Chem; 2010; 17(5):423-52. PubMed ID: 20015038 [TBL] [Abstract][Full Text] [Related]
25. Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives. Urbina JA J Eukaryot Microbiol; 2015; 62(1):149-56. PubMed ID: 25284065 [TBL] [Abstract][Full Text] [Related]
26. Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies. Soeiro Mde N; Dantas AP; Daliry A; Silva CF; Batista DG; de Souza EM; Oliveira GM; Salomão K; Batista MM; Pacheco MG; Silva PB; Santa-Rita RM; Barreto RF; Boykin DW; Castro SL Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():301-10. PubMed ID: 19753489 [TBL] [Abstract][Full Text] [Related]
27. Challenges in Chagas Disease Drug Discovery: A Review. Paucar R; Moreno-Viguri E; Pérez-Silanes S Curr Med Chem; 2016; 23(28):3154-3170. PubMed ID: 27356544 [TBL] [Abstract][Full Text] [Related]
28. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells? Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059 [TBL] [Abstract][Full Text] [Related]
29. The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission. Bartsch SM; Avelis CM; Asti L; Hertenstein DL; Ndeffo-Mbah M; Galvani A; Lee BY PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006809. PubMed ID: 30395603 [TBL] [Abstract][Full Text] [Related]
30. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review. Benaim B; Garcia CR Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874 [TBL] [Abstract][Full Text] [Related]
31. Advances and Progress in Chagas Disease Drug Discovery. Ferreira LG; de Oliveira MT; Andricopulo AD Curr Top Med Chem; 2016; 16(20):2290-302. PubMed ID: 27072717 [TBL] [Abstract][Full Text] [Related]
32. An Updated View of the Martín-Escolano J; Marín C; Rosales MJ; Tsaousis AD; Medina-Carmona E; Martín-Escolano R ACS Infect Dis; 2022 Jun; 8(6):1107-1115. PubMed ID: 35652513 [TBL] [Abstract][Full Text] [Related]
33. Chemotherapy of Chagas disease. Urbina JA Curr Pharm Des; 2002; 8(4):287-95. PubMed ID: 11860367 [TBL] [Abstract][Full Text] [Related]
34. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis. Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058 [TBL] [Abstract][Full Text] [Related]
35. Canine Chagas' disease (American trypanosomiasis) in North America. Barr SC Vet Clin North Am Small Anim Pract; 2009 Nov; 39(6):1055-64, v-vi. PubMed ID: 19932362 [TBL] [Abstract][Full Text] [Related]
37. A new era for chagas disease drug discovery? Keenan M; Chaplin JH Prog Med Chem; 2015; 54():185-230. PubMed ID: 25727705 [TBL] [Abstract][Full Text] [Related]